YAP1 and breast cancer: Mechanistically, the mevalonate cascade produces the geranylgeranyl-pyrophosphate that is required for activation of Rho GTPases that, in turn, activates YAP/TAZ by inhibiting their phosphorylation, thus promoting their nuclear accumulation, as shown in breast cancer cells [69].